Dr. David Sung-yen Yip, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3654 W Anthem Way, Suite B-114, Anthem, AZ 85086 Phone: 623-551-0442 Fax: 623-551-0830 |
News Archive
In the largest, most modern, single-institution study of its kind, Mayo Clinic urologists mined a long-term data registry for survival rates of patients who underwent radical prostatectomy for localized prostate cancer. The findings are being presented at the North Central Section of the American Urological Association's 84th Annual Meeting in Chicago.
In Canada, it is estimated that 22,700 women will be diagnosed with breast cancer and that an estimated 5,400 women will die from the disease this year.
Tuberculosis treatment has saved the lives of more than 22 million people, according to the WHO Global tuberculosis report 2013 published today. The report also reveals that the number of people ill with tuberculosis fell in 2012 to 8.6 million, with global TB deaths also decreasing to 1.3 million.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
Allergan plc, a leading global pharmaceutical company, today announced the availability of TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1mg/20mcg, the first and only oral contraceptive in a softgel capsule for the prevention of pregnancy
› Verified 5 days ago